05/18/2021
7:57 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2021
7:52 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/20/2021
3:16 PM | Sarepta Therapeutics (Filer)
| Form DEFA14A
| |
03/10/2021
7:04 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2021
7:03 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2021
7:02 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4/A
| |
03/10/2021
7:01 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4/A
| |
03/10/2021
7:01 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4/A
| |
03/10/2021
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4/A
| |
03/05/2021
7:06 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/05/2021
7:05 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:05 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:04 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:04 PM | MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:03 PM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:03 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:02 PM | Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:02 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:01 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2021
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/16/2021
10:40 AM | SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G
| |
02/12/2021
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/10/2021
11:30 AM | Capital Research Global Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
02/10/2021
11:26 AM | Capital Research Global Investors (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G
| |
02/01/2021
7:23 AM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
01/11/2021
9:32 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2021
4:03 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2021
7:00 PM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2020
7:05 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2020
7:03 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2020
7:01 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2020
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/14/2020
7:00 PM | Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2020
7:55 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2020
7:24 PM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2020
7:23 PM | Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2020
3:09 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/25/2020
4:06 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
4:22 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2020
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2020
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
7:00 PM | Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2020
7:00 PM | Bratica Joseph (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/09/2020
7:00 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2020
7:40 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2020
8:17 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2020
8:18 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2020
8:05 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2020
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2020
8:02 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2020
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/21/2020
3:19 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A
| |
04/08/2020
3:25 PM | Sarepta Therapeutics (Filer)
| Form PRE 14A
| |
03/06/2020
7:01 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:07 PM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:06 PM | BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:05 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:04 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:04 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:03 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:02 PM | MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:02 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:01 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:01 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2020
7:00 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
7:30 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2020
6:32 AM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
01/21/2020
7:00 PM | MARTIN JOHN C (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2020
11:31 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2020
7:41 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2020
7:00 PM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
7:02 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
7:01 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2019
7:00 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2019
6:59 PM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2019
7:01 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2019
3:25 PM | Sarepta Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/20/2019
7:34 PM | Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2019
7:32 PM | Ciambrone William (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2019
3:03 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/04/2019
7:40 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2019
7:00 AM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
4:17 PM | Sarepta Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/09/2019
1:18 PM | BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2019
1:13 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
6:20 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
4:43 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2019
3:33 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2019
3:38 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2019
4:48 PM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:22 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/07/2019
4:00 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2019
7:07 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2019
7:03 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2019
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2019
3:39 PM | Sarepta Therapeutics (Filer)
| Form DEFA14A
| |
04/26/2019
3:22 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A
| |
04/05/2019
7:30 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
